Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

GlaxoSmithKline PLC

+ Add to Watchlist

GSKN:MM

702.00 MXN 18.00 2.50%

As of 12:40:37 ET on 03/31/2015.

Snapshot for GlaxoSmithKline PLC (GSKN)

Open: 702.00 Day's Range: 702.00 - 702.00 Volume: 1,610
Previous Close: 720.00 52wk Range: 581.90 - 740.00 1-Yr Rtn: +5.10%

Stock Chart for GSKN

No chart data available.
  • GSKN:MM 702.00
  • 1D
  • 1M
  • 1Y
720.00
Interactive GSKN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GSKN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 17.1397
Relative P/E vs. MEXBOL -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2015) 1.8070
Est. PEG Ratio 4.8186
Market Cap (M MXN) 1,707,557.59
Shares Outstanding (M) 2,432.42
30 Day Average Volume 2,867
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 5.92%
Cash Dividend (USD) 0.6952
Dividend Ex-Date 02/18/2015
5 Year Dividend Growth 6.63%
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GSKN

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for GSKN

GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.

Andrew WittyChief Executive OfficerSimon P DingemansChief Financial Officer
David RedfernChief Strategy OfficerMoncef SlaouiChairman:Vaccines
More Company Profile & Key Executives for GSKN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil